Trials are best, ignore the rest: safety and efficacy of digoxin
BMJ
.
2015 Aug 30:351:h4662.
doi: 10.1136/bmj.h4662.
Authors
Graham D Cole
1
,
Darrel P Francis
2
Affiliations
1
International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London W2 1LA, UK g.cole@imperial.ac.uk.
2
International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London W2 1LA, UK.
PMID:
26320880
DOI:
10.1136/bmj.h4662
No abstract available
Publication types
Editorial
Comment
MeSH terms
Atrial Fibrillation / drug therapy*
Cardiotonic Agents / therapeutic use*
Digoxin / therapeutic use*
Heart Failure / drug therapy*
Humans
Substances
Cardiotonic Agents
Digoxin
Grants and funding
FS/10/38/28268/BHF_/British Heart Foundation/United Kingdom
FS/12/12/29294/BHF_/British Heart Foundation/United Kingdom